002693 双成药业
已收盘 10-28 15:00:00
资讯
新帖
简况
图解双成药业三季报：第三季度单季净利润同比下降44.68%
证券之星 · 03:42
图解双成药业三季报：第三季度单季净利润同比下降44.68%
股市必读：双成药业新发布《海南双成药业股份有限公司关于董事、高级管理人员减持计划期限届满暨实施情况的公告》
证券之星 · 10-26
股市必读：双成药业新发布《海南双成药业股份有限公司关于董事、高级管理人员减持计划期限届满暨实施情况的公告》
股市必读：双成药业新发布《海南双成药业股份有限公司关于董事、高级管理人员减持计划期限届满暨实施情况的公告》
证券之星 · 10-23
股市必读：双成药业新发布《海南双成药业股份有限公司关于董事、高级管理人员减持计划期限届满暨实施情况的公告》
双成药业（002693）10月19日主力资金净买入510.29万元
证券之星 · 10-19
双成药业（002693）10月19日主力资金净买入510.29万元
双成药业（002693）10月16日主力资金净卖出2920.09万元
证券之星 · 10-16
双成药业（002693）10月16日主力资金净卖出2920.09万元
双成药业（002693）10月14日主力资金净卖出6361.98万元
证券之星 · 10-14
双成药业（002693）10月14日主力资金净卖出6361.98万元
双成药业（002693）10月13日主力资金净买入9806.57万元
证券之星 · 10-13
双成药业（002693）10月13日主力资金净买入9806.57万元
异动快报：双成药业（002693）10月13日9点58分触及涨停板
证券之星 · 10-13
异动快报：双成药业（002693）10月13日9点58分触及涨停板
双成药业：10月9日高管袁剑琳、艾一祥减持股份合计4.8万股
证券之星 · 10-12
双成药业：10月9日高管袁剑琳、艾一祥减持股份合计4.8万股
双成药业（002693）10月9日主力资金净买入3147.57万元
证券之星 · 10-09
双成药业（002693）10月9日主力资金净买入3147.57万元
双成药业（002693）9月29日主力资金净买入508.85万元
证券之星 · 09-29
双成药业（002693）9月29日主力资金净买入508.85万元
双成药业（002693）9月28日主力资金净买入691.29万元
证券之星 · 09-28
双成药业（002693）9月28日主力资金净买入691.29万元
股市必读：双成药业新发布《海南双成药业股份有限公司关于精氨加压素注射液获得新西兰上市许可的公告》
证券之星 · 09-14
股市必读：双成药业新发布《海南双成药业股份有限公司关于精氨加压素注射液获得新西兰上市许可的公告》
政策东风与产业升级交汇，双成药业站在医药价值重估的风口
证券之星 · 08-31
政策东风与产业升级交汇，双成药业站在医药价值重估的风口
双成药业(002693)6月30日股东户数3.87万户，较上期增加20.23%
证券之星 · 08-22
双成药业(002693)6月30日股东户数3.87万户，较上期增加20.23%
图解双成药业中报：第二季度单季净利润同比增长220.81%
证券之星 · 08-22
图解双成药业中报：第二季度单季净利润同比增长220.81%
双成药业：第六届董事会第六次会议决议公告
经济观察网 · 08-21
双成药业：第六届董事会第六次会议决议公告
股市必读：双成药业新发布《海南双成药业股份有限公司关于控股子公司药品生产许可证变更的公告》
证券之星 · 08-07
股市必读：双成药业新发布《海南双成药业股份有限公司关于控股子公司药品生产许可证变更的公告》
双成药业：8月4日副总经理姚忠减持股份合计4.05万股
证券之星 · 08-05
双成药业：8月4日副总经理姚忠减持股份合计4.05万股
异动快报：双成药业（002693）8月4日9点36分触及涨停板
证券之星 · 08-04
异动快报：双成药业（002693）8月4日9点36分触及涨停板
暂无数据
公司概况
公司名称：
海南双成药业股份有限公司
所属行业：
医药制造业
上市日期：
2012-08-08
主营业务：
海南双成药业股份有限公司的主营业务是药品注射剂、固体制剂、原料药的研发、生产、销售。公司的主要产品是注射用紫杉醇（白蛋白结合型）。
发行价格：
20.00
{"stockData":{"symbol":"002693","market":"SZ","secType":"STK","nameCN":"双成药业","latestPrice":8.68,"timestamp":1793171004000,"preClose":8.6,"halted":0,"volume":12204800,"delay":0,"changeRate":0.0093,"floatShares":411000000,"shares":415000000,"eps":0.1234,"marketStatus":"已收盘","change":0.08,"latestTime":"10-28 15:00:00","open":8.61,"high":8.74,"low":8.46,"amount":105000000,"amplitude":0.0326,"askPrice":8.69,"askSize":432,"bidPrice":8.68,"bidSize":444,"shortable":0,"etf":0,"ttmEps":0.1234,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793237400000},"marketStatusCode":5,"adr":0,"adjPreClose":8.6,"symbolType":"stock","openAndCloseTimeList":[[1793151000000,1793158200000],[1793163600000,1793170800000]],"highLimit":9.46,"lowLimit":7.74,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":414689750,"isCdr":false,"pbRate":8.37,"roa":"--","peRate":70.340357,"roe":"3.25%","epsLYR":0.05,"committee":-0.011298,"marketValue":3600000000,"turnoverRate":0.0297,"status":0,"floatMarketCap":3567000000},"requestUrl":"/m/hq/s/002693/tweets","defaultTab":"tweets","newsList":[{"id":"2679154114","title":"图解双成药业三季报：第三季度单季净利润同比下降44.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679154114","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679154114?lang=zh_cn&edition=full","pubTime":"2026-10-29 03:42","pubTimestamp":1793216544,"startTime":"0","endTime":"0","summary":"证券之星消息，双成药业2026年三季报显示，前三季度公司主营收入1.92亿元，同比上升13.6%；归母净利润2244.8万元，同比上升989.57%；扣非净利润1557.63万元，同比上升365.53%；其中2026年第三季度，公司单季度主营收入7471.92万元，同比下降11.87%；单季度归母净利润882.02万元，同比下降44.68%；单季度扣非净利润467.67万元，同比下降69.13%；负债率47.07%，投资收益-0.02万元，财务费用1099.35万元，毛利率52.6%。财报数据概要请见下图:本文数据来源于双成药业2026年三季报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900003855.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678131049","title":"股市必读：双成药业新发布《海南双成药业股份有限公司关于董事、高级管理人员减持计划期限届满暨实施情况的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2678131049","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678131049?lang=zh_cn&edition=full","pubTime":"2026-10-26 07:01","pubTimestamp":1792969273,"startTime":"0","endTime":"0","summary":"截至2026年10月23日收盘，双成药业报收于9.07元，上涨1.0%，换手率4.48%，成交量18.4万手，成交额1.63亿元。公司公告汇总海南双成药业股份有限公司关于董事、高级管理人员减持计划期限届满暨实施情况的公告海南双成药业股份有限公司于2026年6月30日披露部分董事、高级管理人员减持股份预披露公告，计划在2026年7月22日至10月21日期间通过集中竞价方式减持公司股份合计不超过442,525股。截至2026年10月21日，减持计划期限届满。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600001728.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677599167","title":"股市必读：双成药业新发布《海南双成药业股份有限公司关于董事、高级管理人员减持计划期限届满暨实施情况的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2677599167","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677599167?lang=zh_cn&edition=full","pubTime":"2026-10-23 04:35","pubTimestamp":1792701309,"startTime":"0","endTime":"0","summary":"公司公告汇总海南双成药业股份有限公司关于董事、高级管理人员减持计划期限届满暨实施情况的公告LI JIANMING、袁剑琳、艾一祥、王蕊于2026年7月22日至10月21日期间，分别减持240,000股、81,000股、18,000股、15,525股；减持价格区间分别为9.35–10.32元/股、9.64–10.08元/股、9.80–9.81元/股、10.32元/股；减持后持股数量相应减少，减持过程遵守相关承诺及规定，未发生违规行为。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300004480.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676505440","title":"双成药业（002693）10月19日主力资金净买入510.29万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2676505440","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676505440?lang=zh_cn&edition=full","pubTime":"2026-10-19 15:32","pubTimestamp":1792395126,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月19日收盘，双成药业报收于9.09元，下跌3.5%，换手率8.53%，成交量35.05万手，成交额3.16亿元。10月19日的资金流向数据方面，主力资金净流入510.29万元，占总成交额1.62%，游资资金净流出1483.73万元，占总成交额4.7%，散户资金净流入973.44万元，占总成交额3.08%。双成药业主营业务：涵盖药品注射剂、原料药的研发、生产、销售等。通过逐笔交易单成交金额计算主力资金流向、游资资金流向和散户资金流向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900013464.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675614155","title":"双成药业（002693）10月16日主力资金净卖出2920.09万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675614155","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675614155?lang=zh_cn&edition=full","pubTime":"2026-10-16 15:29","pubTimestamp":1792135791,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月16日收盘，双成药业报收于9.42元，下跌5.14%，换手率10.36%，成交量42.57万手，成交额4.13亿元。10月16日的资金流向数据方面，主力资金净流出2920.09万元，占总成交额7.06%，游资资金净流入1232.64万元，占总成交额2.98%，散户资金净流入1687.44万元，占总成交额4.08%。双成药业主营业务：涵盖药品注射剂、原料药的研发、生产、销售等。通过逐笔交易单成交金额计算主力资金流向、游资资金流向和散户资金流向。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600020996.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675486319","title":"双成药业（002693）10月14日主力资金净卖出6361.98万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675486319","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675486319?lang=zh_cn&edition=full","pubTime":"2026-10-14 15:31","pubTimestamp":1791963100,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月14日收盘，双成药业报收于9.77元，下跌5.33%，换手率13.05%，成交量53.62万手，成交额5.36亿元。10月14日的资金流向数据方面，主力资金净流出6361.98万元，占总成交额11.87%，游资资金净流入886.25万元，占总成交额1.65%，散户资金净流入5475.73万元，占总成交额10.22%。双成药业主营业务：涵盖药品注射剂、原料药的研发、生产、销售等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400020867.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675339563","title":"双成药业（002693）10月13日主力资金净买入9806.57万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675339563","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675339563?lang=zh_cn&edition=full","pubTime":"2026-10-13 15:27","pubTimestamp":1791876451,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月13日收盘，双成药业报收于10.32元，上涨10.02%，换手率7.77%，成交量31.95万手，成交额3.17亿元。10月13日的资金流向数据方面，主力资金净流入9806.57万元，占总成交额30.95%，游资资金净流出4344.74万元，占总成交额13.71%，散户资金净流出5461.82万元，占总成交额17.24%。双成药业主营业务：涵盖药品注射剂、原料药的研发、生产、销售等。通过逐笔交易单成交金额计算主力资金流向、游资资金流向和散户资金流向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300020240.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675381758","title":"异动快报：双成药业（002693）10月13日9点58分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2675381758","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675381758?lang=zh_cn&edition=full","pubTime":"2026-10-13 10:01","pubTimestamp":1791856863,"startTime":"0","endTime":"0","summary":"证券之星10月13日盘中消息，9点58分双成药业（002693）触及涨停板。其所属行业化学制药目前下跌。领涨股为灵康药业。该股为海南概念，肝炎概念，医药概念热股。10月12日的资金流向数据方面，主力资金净流出1642.67万元，占总成交额5.16%，游资资金净流入1466.65万元，占总成交额4.61%，散户资金净流入176.02万元，占总成交额0.55%。近5日资金流向一览见下表：双成药业主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300011023.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674580880","title":"双成药业：10月9日高管袁剑琳、艾一祥减持股份合计4.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2674580880","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674580880?lang=zh_cn&edition=full","pubTime":"2026-10-12 21:01","pubTimestamp":1791810071,"startTime":"0","endTime":"0","summary":"证券之星消息，根据10月12日市场公开信息、上市公司公告及交易所披露数据整理，双成药业（002693）最新董监高及相关人员股份变动情况：2026年10月9日公司高管袁剑琳、高管艾一祥共减持公司股份4.8万股，占公司总股本为0.0115%。变动期间公司股价上涨7.69%，10月9日当日收盘报9.8元。双成药业近半年内的董监高及核心技术人员增减持详情如下：双成药业的高管列表及最新持股情况如下：该股最近90天内无机构评级。本文数据来源于深圳证券交易所信息披露、双成药业公告，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200032993.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674390088","title":"双成药业（002693）10月9日主力资金净买入3147.57万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674390088","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674390088?lang=zh_cn&edition=full","pubTime":"2026-10-09 15:27","pubTimestamp":1791530855,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月9日收盘，双成药业报收于9.8元，上涨7.69%，换手率11.7%，成交量48.08万手，成交额4.63亿元。10月9日的资金流向数据方面，主力资金净流入3147.57万元，占总成交额6.79%，游资资金净流入1339.66万元，占总成交额2.89%，散户资金净流出4487.22万元，占总成交额9.68%。双成药业主营业务：涵盖药品注射剂、原料药的研发、生产、销售等。通过逐笔交易单成交金额计算主力资金流向、游资资金流向和散户资金流向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900018605.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671291115","title":"双成药业（002693）9月29日主力资金净买入508.85万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671291115","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671291115?lang=zh_cn&edition=full","pubTime":"2026-09-29 15:36","pubTimestamp":1790667411,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月29日收盘，双成药业报收于8.96元，下跌1.54%，换手率2.94%，成交量12.09万手，成交额1.09亿元。9月29日的资金流向数据方面，主力资金净流入508.85万元，占总成交额4.65%，游资资金净流出26.37万元，占总成交额0.24%，散户资金净流出482.48万元，占总成交额4.41%。双成药业主营业务：涵盖药品注射剂、原料药的研发、生产、销售等。通过逐笔交易单成交金额计算主力资金流向、游资资金流向和散户资金流向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900020600.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670282858","title":"双成药业（002693）9月28日主力资金净买入691.29万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670282858","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670282858?lang=zh_cn&edition=full","pubTime":"2026-09-28 15:30","pubTimestamp":1790580642,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月28日收盘，双成药业报收于9.1元，上涨1.34%，换手率3.77%，成交量15.49万手，成交额1.41亿元。9月28日的资金流向数据方面，主力资金净流入691.29万元，占总成交额4.91%，游资资金净流入847.77万元，占总成交额6.03%，散户资金净流出1539.06万元，占总成交额10.94%。双成药业主营业务：涵盖药品注射剂、原料药的研发、生产、销售等。通过逐笔交易单成交金额计算主力资金流向、游资资金流向和散户资金流向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800014635.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667680724","title":"股市必读：双成药业新发布《海南双成药业股份有限公司关于精氨加压素注射液获得新西兰上市许可的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667680724","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667680724?lang=zh_cn&edition=full","pubTime":"2026-09-14 02:38","pubTimestamp":1789324693,"startTime":"0","endTime":"0","summary":"公司公告汇总海南双成药业股份有限公司关于精氨加压素注射液获得新西兰上市许可的公告海南双成药业股份有限公司于近日收到新西兰药品和医疗器械安全管理局签发的批准通知，其产品精氨加压素注射液获得新西兰上市许可。此前，该产品已于2025年7月获得澳大利亚药物管理局上市许可。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400001048.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663142026","title":"政策东风与产业升级交汇，双成药业站在医药价值重估的风口","url":"https://stock-news.laohu8.com/highlight/detail?id=2663142026","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663142026?lang=zh_cn&edition=full","pubTime":"2026-08-31 10:10","pubTimestamp":1788142214,"startTime":"0","endTime":"0","summary":"而那些具备扎实研发积淀与全球商业化视野的企业，正在这一轮洗牌中迎来真正的价值的窗口。报告期内，公司实现营业收入1.17亿元，同比增长39.27%；归属于上市公司股东的净利润1,362.78万元，同比增长173.80%；扣非净利润1,089.96万元，同比增长151.86%。分季度看，双成药业二季度营收环比增长41.86%，归母净利润环比增长195.21%。2026年上半年，该产品贡献收入6,153.56万元，占营业总收入的52.52%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026083100006622.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693","09939","159938","BK1161","BK1574","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661216409","title":"双成药业(002693)6月30日股东户数3.87万户，较上期增加20.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661216409","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661216409?lang=zh_cn&edition=full","pubTime":"2026-08-22 17:08","pubTimestamp":1787389716,"startTime":"0","endTime":"0","summary":"证券之星消息，近日双成药业披露，截至2026年6月30日公司股东户数为3.87万户，较3月31日增加6520.0户，增幅为20.23%。户均持股数量由上期的1.29万股减少至1.07万股，户均持股市值为10.13万元。在化学制药行业个股中，双成药业股东户数高于行业平均水平，截至6月30日，化学制药行业平均股东户数为3.67万户。从股价来看，2026年3月31日至2026年6月30日，双成药业区间涨幅为18.7%，在此期间股东户数增加6520.0户，增幅为20.23%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082200014998.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661947632","title":"图解双成药业中报：第二季度单季净利润同比增长220.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661947632","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661947632?lang=zh_cn&edition=full","pubTime":"2026-08-22 01:45","pubTimestamp":1787334306,"startTime":"0","endTime":"0","summary":"证券之星消息，双成药业2026年中报显示，上半年度公司主营收入1.17亿元，同比上升39.27%；归母净利润1362.78万元，同比上升173.8%；扣非净利润1089.96万元，同比上升151.86%；其中2026年第二季度，公司单季度主营收入6871.79万元，同比上升44.83%；单季度归母净利润1017.96万元，同比上升220.81%；单季度扣非净利润804.58万元，同比上升181.06%；负债率47.02%，投资收益-0.02万元，财务费用772.95万元，毛利率55.61%。财报数据概要请见下图:本文数据来源于双成药业2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082200001990.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661969296","title":"双成药业：第六届董事会第六次会议决议公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2661969296","media":"经济观察网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661969296?lang=zh_cn&edition=full","pubTime":"2026-08-21 21:39","pubTimestamp":1787319540,"startTime":"0","endTime":"0","summary":"证券日报网讯 8月21日，双成药业发布公告称，公司第六届董事会第六次会议审议通过《关于2026年半年度报告全文及摘要的议案》。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-08-21/doc-inipavkf6454592.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-08-21/doc-inipavkf6454592.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657659728","title":"股市必读：双成药业新发布《海南双成药业股份有限公司关于控股子公司药品生产许可证变更的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657659728","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657659728?lang=zh_cn&edition=full","pubTime":"2026-08-07 01:40","pubTimestamp":1786038022,"startTime":"0","endTime":"0","summary":"截至2026年8月6日收盘，双成药业报收于9.44元，下跌0.74%，换手率6.55%，成交量26.91万手，成交额2.54亿元。当日关注点交易信息汇总：8月6日主力资金净流入484.6万元，占总成交额1.9%。公司公告汇总：副总经理姚忠减持计划实施完毕，合计减持40,500股，占总股本0.01%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700001733.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657040541","title":"双成药业：8月4日副总经理姚忠减持股份合计4.05万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2657040541","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657040541?lang=zh_cn&edition=full","pubTime":"2026-08-05 20:01","pubTimestamp":1785931287,"startTime":"0","endTime":"0","summary":"证券之星消息，根据8月5日市场公开信息、上市公司公告及交易所披露数据整理，双成药业（002693）最新董监高及相关人员股份变动情况：2026年8月4日公司副总经理姚忠共减持公司股份4.05万股，占公司总股本为0.0098%。变动期间公司股价上涨10.01%，8月4日当日收盘报9.67元。双成药业近半年内的董监高及核心技术人员增减持详情如下：双成药业的高管列表及最新持股情况如下：该股最近90天内无机构评级。本文数据来源于深圳证券交易所信息披露、双成药业公告，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500039527.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656586574","title":"异动快报：双成药业（002693）8月4日9点36分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2656586574","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656586574?lang=zh_cn&edition=full","pubTime":"2026-08-04 09:45","pubTimestamp":1785807940,"startTime":"0","endTime":"0","summary":"证券之星8月4日盘中消息，9点36分双成药业（002693）触及涨停板。其所属行业化学制药目前上涨。领涨股为哈三联。该股为化学原料药，医药，半导体概念热股，当日化学原料药概念上涨2.21%，医药概念上涨2.08%，半导体概念上涨1.67%。8月3日的资金流向数据方面，主力资金净流入108.37万元，占总成交额1.05%，游资资金净流出446.04万元，占总成交额4.34%，散户资金净流入337.67万元，占总成交额3.28%。近5日资金流向一览见下表：双成药业主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400009837.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793230653250,"stockEarnings":[{"period":"1week","weight":-0.0647},{"period":"1month","weight":-0.0462},{"period":"3month","weight":0.0284},{"period":"6month","weight":0.0117},{"period":"1year","weight":0.1114},{"period":"ytd","weight":0.2471}],"compareEarnings":[{"period":"1week","weight":-0.0085},{"period":"1month","weight":-0.0372},{"period":"3month","weight":-0.0324},{"period":"6month","weight":-0.1047},{"period":"1year","weight":-0.0769},{"period":"ytd","weight":-0.0724}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"海南双成药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"42851人(较上一季度增加10.60%)","perCapita":"9590股","listingDate":"2012-08-08","address":"海南省海口市秀英区兴国路16号","registeredCapital":"41468万元","survey":" 海南双成药业股份有限公司的主营业务是药品注射剂、固体制剂、原料药的研发、生产、销售。公司的主要产品是注射用紫杉醇（白蛋白结合型）。","listedPrice":20},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"双成药业(002693)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供双成药业(002693)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"双成药业,002693,双成药业股票,双成药业股票老虎,双成药业股票老虎国际,双成药业行情,双成药业股票行情,双成药业股价,双成药业股市,双成药业股票价格,双成药业股票交易,双成药业股票购买,双成药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"双成药业(002693)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供双成药业(002693)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}